Immune and inflammatory processes in obesity, insulin resistance, diabetes, and related cardiometabolic complications

Journal of Immunology Research

Volumn 2014, Issue , 2014, Pages

  Ndisang, Joseph Fomusi ^a   Rastogi, Sharad ^b   Vannacci, Alfredo ^c  

^a UNIVERSITY OF SASKATCHEWAN   (Canada)

^b HENRY FORD HEART AND VASCULAR INSTITUTE   (United States)

^c UNIVERSITY OF FLORENCE   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

ACUTE CORONARY SYNDROME; ATHEROSCLEROSIS; CARDIOMETABOLIC RISK; CARDIOVASCULAR DISEASE; DIABETES MELLITUS; DIABETIC NEPHROPATHY; DIABETIC RETINOPATHY; EDITORIAL; HEALTH CARE SYSTEM; HUMAN; HYPERTENSION; IMMUNE RESPONSE; INFLAMMATION; INSULIN DEFICIENCY; INSULIN DEPENDENT DIABETES MELLITUS; INSULIN RESISTANCE; NON INSULIN DEPENDENT DIABETES MELLITUS; OBESITY; COMPLICATION; IMMUNOLOGY; MACROPHAGE;

CYTOKINE;

ALLERGY AND IMMUNOLOGY; CARDIOVASCULAR DISEASES; CYTOKINES; DIABETES MELLITUS; HUMANS; INSULIN RESISTANCE; MACROPHAGES; OBESITY;

EID: 84911935959     PISSN: 23148861     EISSN: 23147156     Source Type: Journal    
DOI: 10.1155/2014/579560     Document Type: Editorial

References (20)

1. Hossain P., Kawar B., El Nahas M., Obesity and diabetes in the developing world-a growing challenge. The New England Journal of Medicine 2007 356 3 213 215 10.1056/NEJMp068177 2-s2.0-33846422032
2. WHO, Obesity and overweight. Fact Sheet 2006 311 World Health Organization
3. Ndisang J. F., Role of heme oxygenase in inflammation, insulin-signalling, diabetes and obesity. Mediators of Inflammation 2010 2010 18 359732 10.1155/2010/359732 2-s2.0-77953527349
4. Mishra M., Ndisang J. F., A critical and comprehensive insight on heme oxygenase and related products including carbon monoxide, bilirubin, biliverdin and ferritin in type-1 and type-2 diabetes. Current Pharmaceutical Design 2014 20 9 1370 1391 10.2174/13816128113199990559 2-s2.0-84896346292
5. Tiwari S., Ndisang J. F., The heme oxygenase system and type-1 diabetes. Current Pharmaceutical Design 2014 20 9 1328 1337 10.2174/13816128113199990552 2-s2.0-84896356787
6. Ndisang J. F., Wang R., Age-related alterations in soluble guanylyl cyclase and cGMP pathway in spontaneously hypertensive rats. Journal of Hypertension 2003 21 6 1117 1124 10.1097/00004872-200306000-00011 2-s2.0-0037865221
7. Ndisang J. F., Jadhav A., Upregulating the heme oxygenase system suppresses left ventricular hypertrophy in adult spontaneously hypertensive rats for 3 months. Journal of Cardiac Failure 2009 15 7 616 628 10.1016/j.cardfail.2009.02.003 2-s2.0-68849093674
8. Jadhav A., Ndisang J. F., Heme arginate suppresses cardiac lesions and hypertrophy in deoxycorticosterone acetate-salt hypertension. Experimental Biology and Medicine 2009 234 7 764 778 10.3181/0810-RM-302 2-s2.0-67650260800
9. Ndisang J. F., Wang R., Vannacci A., Marzocca C., Fantappiè O., Mazzanti R., Mannaioni P. F., Masini E., Haeme oxygenase-1 and cardiac anaphylaxis. British Journal of Pharmacology 2001 134 8 1689 1696 10.1038/sj.bjp.0704427 2-s2.0-0035679784
10. Robertson S. A., Ingman W. V., O'Leary S., Sharkey D. J., Tremellen K. P., Transforming growth factor β-a mediator of immune deviation in seminal plasma. Journal of Reproductive Immunology 2002 57 1-2 109 128 10.1016/S0165-0378(02)00015-3 2-s2.0-0037206405
11. Lean I.-S., McDonald S. A. C., Bajaj-Elliott M., Pollok R. C. G., Farthing M. J. G., McDonald V., Interleukin-4 and transforming growth factor β have opposing regulatory effects on gamma interferon-mediated inhibition of Cryptosporidium parvum reproduction. Infection and Immunity 2003 71 8 4580 4585 10.1128/IAI.71.8.4580-4585.2003 2-s2.0-0043267525
12. Leung J. C. K., Chan L. Y. Y., Tsang A. W. L., Liu E. W. L., Lam M. F., Tang S. C. W., Lai K. N., Anti-macrophage migration inhibitory factor reduces transforming growth factor- β 1 expression in experimental IgA nephropathy. Nephrology Dialysis Transplantation 2004 19 8 1976 1985 10.1093/ndt/gfh323 2-s2.0-4344717190
13. Karakaya B., van Moorsel C. H., van der Helm-van Mil A. H., Huizinga T. W., Ruven H. J., van der Vis J. J., Grutters J. C., Macrophage migration inhibitory factor (MIF) -173 polymorphism is associated with clinical erythema nodosum in Lofgren's syndrome. Cytokine 2014 69 2 272 276
14. Coban N., Onat A., Yildirim O., Can G., Erginel-Unaltuna N., Oxidative stress-mediated (sex-specific) loss of protection against type-2 diabetes by macrophage migration inhibitory factor (MIF)-173G/C polymorphism. Clinica Chimica Acta 2014 438 1 6 10.1016/j.cca.2014.07.037
15. McWhorter F. Y., Wang T., Nguyen P., Chung T., Liu W. F., Modulation of macrophage phenotype by cell shape. Proceedings of the National Academy of Sciences of the United States of America 2013 110 43 17253 17258 10.1073/pnas.1308887110 2-s2.0-84886434204
16. Jadhav A., Tiwari S., Lee P., Ndisang J. F., The heme oxygenase system selectively enhances the anti-inflammatory macrophage-m2 phenotype, reduces pericardial adiposity, and ameliorated cardiac injury in diabetic cardiomyopathy in zucker diabetic fatty rats. Journal of Pharmacology and Experimental Therapeutics 2013 345 2 239 249 10.1124/jpet.112.200808 2-s2.0-84876569854
17. Klein B. E. K., Overview of epidemiologic studies of diabetic retinopathy. Ophthalmic Epidemiology 2007 14 4 179 183 10.1080/09286580701396720 2-s2.0-34848907420
18. Lang G. E., Diabetic macular edema. Ophthalmologica 2012 227 supplement 1 21 29 10.1159/000337156 2-s2.0-84860197211
19. Dyer K. H., Silva P. S., Sun J. K., Vascular endothelial growth factor gene polymorphisms and vitreous proteome changes in diabetic retinopathy. Seminars in Ophthalmology 2013 28 5-6 347 354 10.3109/08820538.2013.825284 2-s2.0-84886426676
20. Boyer D. S., Hopkins J. J., Sorof J., Ehrlich J. S., Anti-vascular endothelial growth factor therapy for diabetic macular edema. Therapeutic Advances in Endocrinology and Metabolism 2013 4 6 151 169 10.1177/2042018813512360 2-s2.0-84890104909